TY - STD TI - International Diabetes Federation (IDF). Diabetes atlas - 8th edition. Available at: http://www.diabetesatlas.org/. UR - http://www.diabetesatlas.org/ ID - ref1 ER - TY - JOUR PY - 2013 DA - 2013// TI - Economic costs of diabetes in the U.S. in 2012 JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-2625 DO - 10.2337/dc12-2625 ID - ref2 ER - TY - JOUR AU - Jonsson, B. PY - 2002 DA - 2002// TI - Revealing the cost of type II diabetes in Europe JO - Diabetologia. VL - 45 UR - https://doi.org/10.1007/s00125-002-0858-x DO - 10.1007/s00125-002-0858-x ID - Jonsson2002 ER - TY - JOUR PY - 2018 DA - 2018// TI - Economic costs of diabetes in the U.S. in 2017 JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dci18-0007 DO - 10.2337/dci18-0007 ID - ref4 ER - TY - JOUR AU - Stratton, I. M. AU - Adler, A. I. AU - Neil, H. A. AU - Matthews, D. R. AU - Manley, S. E. AU - Cull, C. A. PY - 2000 DA - 2000// TI - Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study JO - BMJ. VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.405 DO - 10.1136/bmj.321.7258.405 ID - Stratton2000 ER - TY - JOUR PY - 1993 DA - 1993// TI - The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309303291401 DO - 10.1056/NEJM199309303291401 ID - ref6 ER - TY - BOOK PY - 2016 DA - 2016// TI - Good clinical practice guidelines on diabetes mellitus ID - ref7 ER - TY - JOUR AU - Davies, M. J. AU - D'Alessio, D. A. AU - Fradkin, J. AU - Kernan, W. N. AU - Mathieu, C. AU - Mingrone, G. PY - 2018 DA - 2018// TI - Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dci18-0033 DO - 10.2337/dci18-0033 ID - Davies2018 ER - TY - JOUR AU - Giugliano, D. AU - Maiorino, M. I. AU - Bellastella, G. AU - Chiodini, P. AU - Ceriello, A. AU - Esposito, K. PY - 2011 DA - 2011// TI - Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc10-1710 DO - 10.2337/dc10-1710 ID - Giugliano2011 ER - TY - BOOK PY - 2012 DA - 2012// TI - Clinical Guidelines Task Force. Global guideline for type 2 diabetes ID - ref10 ER - TY - JOUR PY - 2018 DA - 2018// TI - Standards of medical care in diabetes-2018 JO - Diabetes Care VL - 41 ID - ref11 ER - TY - JOUR AU - Blak, B. T. AU - Smith, H. T. AU - Hards, M. AU - Curtis, B. H. AU - Ivanyi, T. PY - 2012 DA - 2012// TI - Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin JO - Diabet Med VL - 29 UR - https://doi.org/10.1111/j.1464-5491.2012.03586.x DO - 10.1111/j.1464-5491.2012.03586.x ID - Blak2012 ER - TY - JOUR AU - Pablos-Velasco, P. AU - Parhofer, K. G. AU - Bradley, C. AU - Eschwege, E. AU - Gonder-Frederick, L. AU - Maheux, P. PY - 2014 DA - 2014// TI - Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study JO - Clin Endocrinol (Oxf) VL - 80 UR - https://doi.org/10.1111/cen.12119 DO - 10.1111/cen.12119 ID - Pablos-Velasco2014 ER - TY - JOUR AU - Govan, L. AU - Wu, O. AU - Briggs, A. AU - Colhoun, H. M. AU - Fischbacher, C. M. AU - Leese, G. P. PY - 2011 DA - 2011// TI - Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes research network epidemiology group JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc10-2099 DO - 10.2337/dc10-2099 ID - Govan2011 ER - TY - STD TI - NHS Health & Social Care Information Centre. National Diabetes Audit 2011–2012; Report 1: Care Processes and Treatment Targets, Available at http://content.digital.nhs.uk/catalogue/PUB12421/nati-diab-audi-11-12-care-proc-rep.pdf. UR - http://content.digital.nhs.uk/catalogue/PUB12421/nati-diab-audi-11-12-care-proc-rep.pdf ID - ref15 ER - TY - JOUR AU - Cokolic, M. AU - Lalic, N. M. AU - Micic, D. AU - Mirosevic, G. AU - Klobucar Majanovic, S. AU - Lefterov, I. N. PY - 2017 DA - 2017// TI - Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania JO - Wien Klin Wochenschr VL - 129 UR - https://doi.org/10.1007/s00508-016-1143-1 DO - 10.1007/s00508-016-1143-1 ID - Cokolic2017 ER - TY - JOUR AU - Calvert, M. J. AU - McManus, R. J. AU - Freemantle, N. PY - 2007 DA - 2007// TI - Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study JO - Br J Gen Pract VL - 57 ID - Calvert2007 ER - TY - JOUR AU - Rubino, A. AU - McQuay, L. J. AU - Gough, S. C. AU - Kvasz, M. AU - Tennis, P. PY - 2007 DA - 2007// TI - Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK JO - Diabet Med VL - 24 UR - https://doi.org/10.1111/j.1464-5491.2007.02279.x DO - 10.1111/j.1464-5491.2007.02279.x ID - Rubino2007 ER - TY - JOUR AU - Peyrot, M. AU - Rubin, R. R. AU - Lauritzen, T. AU - Skovlund, S. E. AU - Snoek, F. J. AU - Matthews, D. R. PY - 2005 DA - 2005// TI - Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes attitudes, wishes, and needs (DAWN) study JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.11.2673 DO - 10.2337/diacare.28.11.2673 ID - Peyrot2005 ER - TY - JOUR AU - Heise, T. AU - Nosek, L. AU - Bottcher, S. G. AU - Hastrup, H. AU - Haahr, H. PY - 2012 DA - 2012// TI - Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01638.x DO - 10.1111/j.1463-1326.2012.01638.x ID - Heise2012 ER - TY - JOUR AU - Haahr, H. AU - Heise, T. PY - 2014 DA - 2014// TI - A review of the pharmacological properties of insulin degludec and their clinical relevance JO - Clin Pharmacokinet VL - 53 UR - https://doi.org/10.1007/s40262-014-0165-y DO - 10.1007/s40262-014-0165-y ID - Haahr2014 ER - TY - JOUR AU - Heise, T. AU - Hermanski, L. AU - Nosek, L. AU - Feldman, A. AU - Rasmussen, S. AU - Haahr, H. PY - 2012 DA - 2012// TI - Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2012.01627.x DO - 10.1111/j.1463-1326.2012.01627.x ID - Heise2012 ER - TY - JOUR AU - Heise, T. AU - Norskov, M. AU - Nosek, L. AU - Kaplan, K. AU - Famulla, S. AU - Haahr, H. L. PY - 2017 DA - 2017// TI - Insulin degludec: lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes JO - Diabetes Obes Metab VL - 19 UR - https://doi.org/10.1111/dom.12938 DO - 10.1111/dom.12938 ID - Heise2017 ER - TY - JOUR AU - Heise, T. AU - Kaplan, K. AU - Haahr, H. L. PY - 2018 DA - 2018// TI - Day-to-day and within-day variability in glucose-lowering effect between insulin Degludec and insulin Glargine (100 U/mL and 300 U/mL): a comparison across studies JO - J Diabetes Sci Technol VL - 12 UR - https://doi.org/10.1177/1932296817731422 DO - 10.1177/1932296817731422 ID - Heise2018 ER - TY - STD TI - European Medicines Agency. Tresiba® (insulin degludec) Summary of Product Characteristics. Available at: https://www.ema.europa.eu/documents/product-information/tresiba-epar-product-information_en.pdf. UR - https://www.ema.europa.eu/documents/product-information/tresiba-epar-product-information_en.pdf ID - ref25 ER - TY - JOUR AU - Wangnoo, S. K. AU - Chowdhury, S. AU - Rao, P. V. PY - 2014 DA - 2014// TI - Treating to target in type 2 diabetes: the BEGIN trial programme JO - J Assoc Physicians India VL - 62 ID - Wangnoo2014 ER - TY - JOUR AU - Vora, J. AU - Christensen, T. AU - Rana, A. AU - Bain, S. C. PY - 2014 DA - 2014// TI - Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trials JO - Diab Therapy VL - 5 UR - https://doi.org/10.1007/s13300-014-0076-9 DO - 10.1007/s13300-014-0076-9 ID - Vora2014 ER - TY - JOUR AU - Ratner, R. AU - Gough, S. C. AU - Mathieu, C. AU - Prato, S. D. AU - Bode, B. AU - Mersebach, H. PY - 2013 DA - 2013// TI - Hypoglycaemia risk with insulin Degludec compared with insulin Glargine in type 2 and type 1 Diabetes: a pre-planned meta-analysis of phase 3 trials JO - Diabetes Obes Metab VL - 15 UR - https://doi.org/10.1111/dom.12032 DO - 10.1111/dom.12032 ID - Ratner2013 ER - TY - JOUR AU - Siegmund, T. AU - Tentolouris, N. AU - Knudsen, S. T. AU - Lapolla, A. AU - Prager, R. AU - Phan, T. M. PY - 2018 DA - 2018// TI - A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes JO - Diabetes Obes Metab VL - 20 UR - https://doi.org/10.1111/dom.13149 DO - 10.1111/dom.13149 ID - Siegmund2018 ER - TY - JOUR AU - Evans, M. AU - McEwan, P. AU - Foos, V. PY - 2015 DA - 2015// TI - Insulin degludec early clinical experience: does the promise from the clinical trials translate into clinical practice-a case-based evaluation JO - J Med Econ VL - 18 UR - https://doi.org/10.3111/13696998.2014.975234 DO - 10.3111/13696998.2014.975234 ID - Evans2015 ER - TY - JOUR AU - Sassi, F. PY - 2006 DA - 2006// TI - Calculating QALYs, comparing QALY and DALY calculations JO - Health Policy Plan VL - 21 UR - https://doi.org/10.1093/heapol/czl018 DO - 10.1093/heapol/czl018 ID - Sassi2006 ER - TY - BOOK PY - 2001 DA - 2001// TI - Report of the Commission on Macroeconomics and Health PB - World Health Organization CY - Geneva ID - ref32 ER - TY - JOUR AU - Evans, M. AU - Chubb, B. AU - Gundgaard, J. PY - 2017 DA - 2017// TI - Cost-effectiveness of insulin degludec versus insulin glargine in adults with type 1 and type 2 diabetes mellitus JO - Diab Therapy VL - 8 UR - https://doi.org/10.1007/s13300-017-0236-9 DO - 10.1007/s13300-017-0236-9 ID - Evans2017 ER - TY - JOUR AU - Lalic, N. AU - Russel-Szymczyk, M. AU - Culic, M. AU - Tikkanen, C. K. AU - Chubb, B. PY - 2018 DA - 2018// TI - Cost-effectiveness of insulin Degludec versus insulin Glargine U100 in patients with type 1 and type 2 Diabetes mellitus in Serbia JO - Diab Therapy VL - 9 UR - https://doi.org/10.1007/s13300-018-0426-0 DO - 10.1007/s13300-018-0426-0 ID - Lalic2018 ER - TY - JOUR AU - Doneva, M. AU - Valov, V. AU - Borisova, A. -. M. AU - Tankova, T. AU - Savova, A. AU - Manova, M. PY - 2013 DA - 2013// TI - Comparative Analysis of the Cost of Insulin Treated Patients in Bulgaria JO - Biotechnol Biotechnologic Equip VL - 27 UR - https://doi.org/10.5504/BBEQ.2013.0001 DO - 10.5504/BBEQ.2013.0001 ID - Doneva2013 ER - TY - JOUR PY - 2007 DA - 2007// TI - Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration JO - Diabetologia. VL - 50 UR - https://doi.org/10.1007/s00125-007-0599-y DO - 10.1007/s00125-007-0599-y ID - ref36 ER - TY - JOUR AU - Brod, M. AU - Rana, A. AU - Barnett, A. H. PY - 2012 DA - 2012// TI - Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians JO - Curr Med Res Opin VL - 28 UR - https://doi.org/10.1185/03007995.2012.743457 DO - 10.1185/03007995.2012.743457 ID - Brod2012 ER - TY - JOUR AU - Ericsson, A. AU - Pollock, R. F. AU - Hunt, B. AU - Valentine, W. J. PY - 2013 DA - 2013// TI - Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden JO - J Med Econ VL - 16 UR - https://doi.org/10.3111/13696998.2013.852099 DO - 10.3111/13696998.2013.852099 ID - Ericsson2013 ER - TY - JOUR AU - Ostenson, C. G. AU - Geelhoed-Duijvestijn, P. AU - Lahtela, J. AU - Weitgasser, R. AU - Markert Jensen, M. AU - Pedersen-Bjergaard, U. PY - 2014 DA - 2014// TI - Self-reported non-severe hypoglycaemic events in Europe JO - Diabet Med VL - 31 UR - https://doi.org/10.1111/dme.12261 DO - 10.1111/dme.12261 ID - Ostenson2014 ER - TY - JOUR AU - Heller, S. R. AU - Frier, B. M. AU - Herslov, M. L. AU - Gundgaard, J. AU - Gough, S. C. PY - 2016 DA - 2016// TI - Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources JO - Diabet Med VL - 33 UR - https://doi.org/10.1111/dme.12844 DO - 10.1111/dme.12844 ID - Heller2016 ER - TY - JOUR AU - Boye, K. S. AU - Matza, L. S. AU - Walter, K. N. AU - Brunt, K. AU - Palsgrove, A. C. AU - Tynan, A. PY - 2011 DA - 2011// TI - Utilities and disutilities for attributes of injectable treatments for type 2 diabetes JO - Eur J Health Econ VL - 12 UR - https://doi.org/10.1007/s10198-010-0224-8 DO - 10.1007/s10198-010-0224-8 ID - Boye2011 ER - TY - JOUR AU - Evans, M. AU - Jensen, H. H. AU - Bogelund, M. AU - Gundgaard, J. AU - Chubb, B. AU - Khunti, K. PY - 2013 DA - 2013// TI - Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey JO - J Med Econ VL - 16 UR - https://doi.org/10.3111/13696998.2013.846262 DO - 10.3111/13696998.2013.846262 ID - Evans2013 ER - TY - JOUR AU - Pollock, R. F. AU - Tikkanen, C. K. PY - 2017 DA - 2017// TI - A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark JO - J Med Econ VL - 20 UR - https://doi.org/10.1080/13696998.2016.1245663 DO - 10.1080/13696998.2016.1245663 ID - Pollock2017 ER - TY - JOUR AU - Evans, M. AU - Wolden, M. AU - Gundgaard, J. AU - Chubb, B. AU - Christensen, T. PY - 2014 DA - 2014// TI - Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12250 DO - 10.1111/dom.12250 ID - Evans2014 ER - TY - JOUR AU - Evans, M. AU - Wolden, M. AU - Gundgaard, J. AU - Chubb, B. AU - Christensen, T. PY - 2015 DA - 2015// TI - Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK JO - J Med Econ VL - 18 UR - https://doi.org/10.3111/13696998.2014.971160 DO - 10.3111/13696998.2014.971160 ID - Evans2015 ER - TY - JOUR AU - Frier, B. M. PY - 2011 DA - 2011// TI - The economic costs of hypoglycaemia JO - Br J Diabetes Vasc Dis VL - 11 UR - https://doi.org/10.1177/1474651410377558 DO - 10.1177/1474651410377558 ID - Frier2011 ER - TY - JOUR AU - Khunti, K. AU - Davies, M. AU - Majeed, A. AU - Thorsted, B. L. AU - Wolden, M. L. AU - Paul, S. K. PY - 2015 DA - 2015// TI - Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study JO - Diabetes Care VL - 38 UR - https://doi.org/10.2337/dc14-0920 DO - 10.2337/dc14-0920 ID - Khunti2015 ER - TY - JOUR AU - Graveling, A. J. AU - Frier, B. M. PY - 2010 DA - 2010// TI - Impaired awareness of hypoglycaemia: a review JO - Diabetes Metab VL - 36 UR - https://doi.org/10.1016/S1262-3636(10)70470-5 DO - 10.1016/S1262-3636(10)70470-5 ID - Graveling2010 ER - TY - JOUR AU - Khunti, K. AU - Alsifri, S. AU - Aronson, R. AU - Cigrovski Berkovic, M. AU - Enters-Weijnen, C. AU - Forsen, T. PY - 2016 DA - 2016// TI - Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12689 DO - 10.1111/dom.12689 ID - Khunti2016 ER - TY - JOUR AU - Landstedt-Hallin, L. AU - Gundgaard, J. AU - Ericsson, A. AU - Ellfors-Zetterlund, S. PY - 2017 DA - 2017// TI - Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data JO - Curr Med Res Opin VL - 33 UR - https://doi.org/10.1080/03007995.2016.1277194 DO - 10.1080/03007995.2016.1277194 ID - Landstedt-Hallin2017 ER - TY - JOUR AU - Peyrot, M. AU - Barnett, A. H. AU - Meneghini, L. F. AU - Schumm-Draeger, P. M. PY - 2012 DA - 2012// TI - Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study JO - Diabet Med VL - 29 UR - https://doi.org/10.1111/j.1464-5491.2012.03605.x DO - 10.1111/j.1464-5491.2012.03605.x ID - Peyrot2012 ER - TY - JOUR AU - Khunti, K. AU - Alsifri, S. AU - Aronson, R. AU - Cigrovski Berkovic, M. AU - Enters-Weijnen, C. AU - Forsen, T. PY - 2017 DA - 2017// TI - Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes JO - Diabetes Res Clin Pract VL - 130 UR - https://doi.org/10.1016/j.diabres.2017.05.004 DO - 10.1016/j.diabres.2017.05.004 ID - Khunti2017 ER - TY - BOOK PY - 2016 DA - 2016// TI - Facts and stats ID - ref53 ER - TY - JOUR AU - Lane, W. AU - Bailey, T. S. AU - Gerety, G. AU - Gumprecht, J. AU - Philis-Tsimikas, A. AU - Hansen, C. T. PY - 2017 DA - 2017// TI - Effect of insulin Degludec vs insulin Glargine U100 on hypoglycemia in patients with type 1 Diabetes: the SWITCH 1 randomized clinical trial JO - JAMA. VL - 318 UR - https://doi.org/10.1001/jama.2017.7115 DO - 10.1001/jama.2017.7115 ID - Lane2017 ER - TY - JOUR AU - Wysham, C. AU - Bhargava, A. AU - Chaykin, L. AU - Rosa, R. AU - Handelsman, Y. AU - Troelsen, L. N. PY - 2017 DA - 2017// TI - Effect of insulin Degludec vs insulin Glargine U100 on hypoglycemia in patients with type 2 Diabetes: the SWITCH 2 randomized clinical trial JO - JAMA. VL - 318 UR - https://doi.org/10.1001/jama.2017.7117 DO - 10.1001/jama.2017.7117 ID - Wysham2017 ER - TY - JOUR AU - Evans, M. AU - Mehta, R. AU - Gundgaard, J. AU - Chubb, B. PY - 2018 DA - 2018// TI - Cost-effectiveness of insulin degludec vs. insulin glargine U100 in type 1 and type 2 diabetes mellitus in a UK setting JO - Diab Therapy VL - 9 UR - https://doi.org/10.1007/s13300-018-0478-1 DO - 10.1007/s13300-018-0478-1 ID - Evans2018 ER - TY - JOUR AU - Philis-Tsimikas, A. AU - Brod, M. AU - Niemeyer, M. AU - Ocampo Francisco, A. M. AU - Rothman, J. PY - 2013 DA - 2013// TI - Insulin Degludec once-daily in type 2 Diabetes: simple or step-wise titration (BEGIN: once simple use) JO - Adv Ther VL - 30 UR - https://doi.org/10.1007/s12325-013-0036-1 DO - 10.1007/s12325-013-0036-1 ID - Philis-Tsimikas2013 ER - TY - JOUR AU - Marso, S. P. AU - McGuire, D. K. AU - Zinman, B. AU - Poulter, N. R. AU - Emerson, S. S. AU - Pieber, T. R. PY - 2017 DA - 2017// TI - Efficacy and safety of degludec versus glargine in type 2 diabetes JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1615692 DO - 10.1056/NEJMoa1615692 ID - Marso2017 ER -